Skip to main content
Livermore
Livermore
ZHEN

Oncternal Therapeutics, Inc.

ONCTDelisted Mar 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001260990

Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Oncternal Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
−10 vs. Q3 2023
Shares held
8.45M
−882.7K (−9.5%) vs. Q3 2023
Total value
$4.53M
+$1.72M (+61.4%) vs. Q3 2023
New holders
4
5 more added
Sold out
14
9 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ONCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 41 institutions
Q1 2021: 67 institutionsQ2 2021: 85 institutionsQ3 2021: 77 institutionsQ4 2021: 84 institutionsQ1 2022: 79 institutionsQ2 2022: 75 institutionsQ3 2022: 61 institutionsQ4 2022: 59 institutionsQ1 2023: 55 institutionsQ2 2023: 53 institutionsQ3 2023: 52 institutionsQ4 2023: 41 institutionsQ1 2024: 24 institutionsQ2 2024: 26 institutionsQ3 2024: 23 institutionsQ4 2024: 4 institutionsQ1 2025: 0 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 2 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2023: $4.53M
Q1 2021: $82.5MQ2 2021: $65.2MQ3 2021: $56.8MQ4 2021: $30.5MQ1 2022: $18.6MQ2 2022: $12.6MQ3 2022: $8.79MQ4 2022: $9.31MQ1 2023: $7.86MQ2 2023: $3.26MQ3 2023: $2.81MQ4 2023: $4.53MQ1 2024: $4.05MQ2 2024: $3.67MQ3 2024: $471.0KQ4 2024: $10Q1 2025: $0Q2 2025: $74Q3 2025: $73Q4 2025: $169Q1 2026: $74Q2 2026: $75
Institutions holding ONCT and their total value by quarter
QuarterHoldersValue
Q2 20261$75
Q1 20261$74
Q4 20252$169
Q3 20251$73
Q2 20251$74
Q1 20250$0
Q4 20244$10
Q3 202423$471.0K
Q2 202426$3.67M
Q1 202424$4.05M
Q4 202341$4.53M
Q3 202352$2.81M
Q2 202353$3.26M
Q1 202355$7.86M
Q4 202259$9.31M
Q3 202261$8.79M
Q2 202275$12.6M
Q1 202279$18.6M
Q4 202184$30.5M
Q3 202177$56.8M
Q2 202185$65.2M
Q1 202167$82.5M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Oncternal Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding ONCT in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc2,860,906$1.53M0.00%00.0%Unchanged
Millennium Management LLC2,055,904$1.10M0.00%+408,660+24.8%Added
BlackRock Inc.785,681$421.3K0.00%00.0%Unchanged
Pasadena Private Wealth, LLC500,000$268.1K0.07%+221,250+79.4%Added
Richmond Brothers, Inc.494,042$264.9K0.46%00.0%Unchanged
Renaissance Technologies LLC327,200$175.0K0.00%+13,900+4.4%Added
LPL Financial LLC171,459$91.9K0.00%00.0%Unchanged
State Street Corp161,401$86.5K0.00%00.0%Unchanged
Ieq Capital, LLC144,434$77.4K0.00%00.0%Unchanged
Morgan Stanley92,980$49.9K0.00%−5,000−5.1%Reduced
Northern Trust Corp84,706$45.4K0.00%00.0%Unchanged
Two Sigma Advisers, LP83,600$44.8K0.00%−14,800−15.0%Reduced
Two Sigma Investments, LP74,681$40.0K0.00%00.0%Unchanged
Acadian Asset Management LLC72,775$38.0K0.00%00.0%Unchanged
Axxcess Wealth Management, LLC70,363$37.7K0.00%00.0%Unchanged
Two Sigma Securities, LLC58,761$31.5K0.00%+37,537+176.9%Added
Citadel Advisors LLC54,279$29.1K0.00%+54,279New
Regents of the University of California53,554$28.7K0.00%00.0%Unchanged
Balboa Wealth Partners47,500$25.5K0.01%00.0%Unchanged
Creative Planning39,318$21.1K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc32,249$17.3K0.00%00.0%Unchanged
Beta Wealth Group, Inc.32,000$17.2K0.01%00.0%Unchanged
Aureus Asset Management, LLC30,211$16.2K0.00%00.0%Unchanged
Valeo Financial Advisors, LLC23,536$12.6K0.00%−11,000−31.9%Reduced
IPG Investment Advisors LLC23,319$12.5K0.00%+23,319New
JPMorgan Chase & Co20,087$10.8K0.00%00.0%Unchanged
XTX Topco Ltd19,505$10.5K0.00%+19,505New
Advisor Group Holdings, Inc.8,850$4.75K0.00%−3,600−28.9%Reduced
Wells Fargo & Company6,417$3.44K0.00%+21+0.3%Added
North Star Investment Management Corp.5,000$2.68K0.00%−5,000−50.0%Reduced
Tower Research Capital LLC (TRC)4,962$2.66K0.00%−14,366−74.3%Reduced
BNP Paribas Arbitrage, SA3,645$1.95K0.00%00.0%Unchanged
UBS Group AG2,000$1.07K0.00%−11,582−85.3%Reduced
Truvestments Capital LLC440$2360.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC300$1610.00%00.0%Unchanged
Lindbrook Capital, LLC300$1610.00%00.0%Unchanged
Bank of America Corp35$190.00%−5,965−99.4%Reduced
Coppell Advisory Solutions LLC20$110.00%−38−65.5%Reduced
Delta Asset Management LLC7$40.00%00.0%Unchanged
Cetera Trust Company, N.A7$40.00%+7New
Qube Research & Technologies Ltd1$10.00%00.0%Unchanged
Geode Capital Management, LLC0$00.00%−475,945−100.0%Sold out
Quantum Private Wealth, LLC0$00.00%−459,187−100.0%Sold out
Brighton Jones LLC0$00.00%−338,491−100.0%Sold out
CI Private Wealth, LLC0$00.00%−91,579−100.0%Sold out
Envestnet Asset Management Inc0$00.00%−53,911−100.0%Sold out
Mercer Global Advisors Inc0$00.00%−53,973−100.0%Sold out
Waypoint Capital Advisors, LLC0$00.00%−26,271−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−22,393−100.0%Sold out
Mackenzie Financial Corp0$00.00%−19,944−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−17,600−100.0%Sold out
Jane Street Group, LLC0$00.00%−10,288−100.0%Sold out
Royal Bank of Canada0$00.00%−10,000−100.0%Sold out
Baader Bank INC0$00.00%−10,149−100.0%Sold out
Nemes Rush Group LLC0$00.00%−71−100.0%Sold out
Column Capital Advisors, LLC––––Not filed